US Patent Issued to QATAR UNIVERSITY on Sept. 30 for "Chalcone-based chemotherapeutic compound for triple negative breast cancer" (Qatari Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,405, issued on Sept. 30, was assigned to QATAR UNIVERSITY (Doha, Qatar).

"Chalcone-based chemotherapeutic compound for triple negative breast cancer" was invented by Ashraf Khalil (Doha, Qatar), Ala-Eddin Al Moustafa (Doha, Qatar), Dana H. Elkhalifa (Doha, Qatar) and Feras Alali (Doha, Qatar).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, compositions, and methods useful for the treatment of breast cancer, particularly triple negative breast cancers. In certain aspects, provided herein are compounds of formula (I):or a pharmaceutically acceptable salt or solvate thereof. In certain aspects, provided herein are composit...